{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:34Z","timestamp":1753891594654,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Pompe disease is an autosomal recessive hereditary lysosomal disorder and correlated with acid \u03b1-glucosidase enzyme (GAA) deficiencies, which lead to accumulation of glycogen in all tissues, most notably in skeletal muscles. Adult late-onset Pompe disease (LOPD) is a slowly progressive disease of proximal myopathy with later involvement of the respiratory muscles, resulting in respiratory failure. In this study, we reported a 22-year-old Chinese woman with inability to withstand heavy physical activity since childhood, who presented with respiratory and ambulation weakness in 2 months. On admission, her bilateral upper limbs strength was 4\/5 and lower limbs strength was 3\/5 according to Medical Research Council (MRC) score. The patient had compound heterozygotes containing a newly identified 4 nt deletion of coding sequence (deletion nt 1411_1414) in one of the acid \u03b1-glucosidase alleles and a c.2238G&amp;gt;C (p.Trp746Cys) missense mutation. This deletion has been reported in infant-onset Pompe disease (IOPD) but not LOPD. Intriguingly, this deletion mutation was not found in the patient's family and was considered as pathogenic. Muscle biopsy showed scattered vacuoles with basophilic granules inside the subsarcolemmal area, which were strongly stained by periodic acid-Schiff (PAS). Laboratory tests revealed a significant increase of creatine kinase MB isoenzyme (CK-MB) and lactate dehydrogenase (LDH). GAA level was 9.77 nmol\/1 h\/mg and was not sufficient for the diagnosis of GAA activity deficiency (0\u20133.78 nmol\/1 h\/mg). In summary, mutational analysis of GAA and muscle biopsy are crucial in the diagnosis of Pompe disease.<\/jats:p>","DOI":"10.3389\/fneur.2022.839263","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:39:16Z","timestamp":1647880756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Identification of Compound Heterozygous Mutations in a Patient With Late-Onset Glycogen Storage Disease Type II (Pompe Disease)"],"prefix":"10.3389","volume":"13","author":[{"given":"Huiting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangtao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"Van der Ploeg","year":"2008","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"636731","DOI":"10.3389\/fimmu.2021.636731","article-title":"Immune tolerance-adjusted personalized immunogenicity prediction for Pompe Disease","volume":"12","author":"De Groot","year":"2021","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/humu.23854","article-title":"Extension of the Pompe mutation database by linking disease-associated variants to clinical severity","volume":"40","author":"Ni\u00f1o","year":"2019","journal-title":"Hum Mutat."},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cca.2013.10.013","article-title":"Development of a feasible assay for the detection of GAA mutations in patients with Pompe disease","volume":"429","author":"Er","year":"2014","journal-title":"Clin Chim Acta"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101435","DOI":"10.1016\/j.scr.2019.101435","article-title":"A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p","volume":"37","author":"Cheng","year":"2019","journal-title":"Stem Cell Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur J Hum Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.3390\/ijms22062850","article-title":"Muscle proteomic profile before and after enzyme replacement therapy in late-onset Pompe Disease","volume":"22","author":"Moriggi","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ymgme.2021.05.005","article-title":"Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired\/hereditary myopathy","volume":"133","author":"Jones","year":"2021","journal-title":"Mol Genet Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.arbr.2019.02.008","article-title":"Can right heart failure cause pleural effusion?","volume":"55","author":"Ferreiro","year":"2019","journal-title":"Arch Bronconeumol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s10072-020-04819-2","article-title":"Intracranial aneurysm management in patients with late-onset Pompe disease (LOPD)","volume":"42","author":"Mormina","year":"2021","journal-title":"Neurol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset Pompe disease: a systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol Genet Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.2169\/internalmedicine.50.5563","article-title":"Novel mutations in the gene encoding acid \u03b1-1,4-glucosidase in a patient with late-onset glycogen storage disease type II (Pompe disease) with impaired intelligence","volume":"50","author":"Muraoka","year":"2011","journal-title":"Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/j.1460-2075.1988.tb02998.x","article-title":"Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex","volume":"7","author":"Hoefsloot","year":"1988","journal-title":"EMBO J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1006\/bbrc.1996.0231","article-title":"Identification of a small deletion in one allele of patients with infantile form of glycogen storage disease type II","volume":"219","author":"Shieh","year":"1996","journal-title":"Biochem Biophys Res Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00415-008-0714-0","article-title":"Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II","volume":"255","author":"Wan","year":"2008","journal-title":"J Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13023-019-1054-0","article-title":"Characteristics of Pompe disease in China: a report from the Pompe registry","volume":"14","author":"Zhao","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s10038-007-0191-9","article-title":"Structural and biochemical studies on Pompe disease and a \u201cpseudodeficiency of acid alpha-glucosidase\u201d","volume":"52","author":"Tajima","year":"2007","journal-title":"J Hum Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"15856","DOI":"10.18632\/aging.103794","article-title":"Pompe disease: pathogenesis, molecular genetics and diagnosis","volume":"12","author":"Taverna","year":"2020","journal-title":"Aging."},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2009.03.004","article-title":"High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population","volume":"9","author":"Kumamoto","year":"2009","journal-title":"Mol Genet Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.18632\/aging.102879","article-title":"GAA compound heterozygous mutations associated with autophagic impairment cause cerebral infarction in Pompe disease","volume":"12","author":"Jia","year":"2020","journal-title":"Aging"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.839263\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:39:22Z","timestamp":1647880762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.839263\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":22,"alternative-id":["10.3389\/fneur.2022.839263"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.839263","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"article-number":"839263"}}